Cerenome, Inc. (CNSY) vs Medicus Pharma Ltd. Common Stock (MDCX)
A side-by-side comparison of Cerenome, Inc. and Medicus Pharma Ltd. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNSY
Cerenome, Inc.
$1.63HealthcareDelayed quote: Oct 6, 2026, 12:02 PM EDT
MDCX
Medicus Pharma Ltd. Common Stock
$0.16HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — CNSY vs MDCX
growth of $100 · dividends reinvested · last 1yCNSY -61.5% (-61.5%/yr)MDCX -63.7% (-63.7%/yr)CNSY compounded faster over this window
CNSY MDCX
CNSY vs MDCX: by the numbers
- •CNSY is the larger company ($11M vs $10M market cap).
- •Both run net losses; MDCX's is the smaller (0.00% vs -620.70% net margin).
Metrics side by side
Valuation
| Metric | CNSY | MDCX |
|---|---|---|
| P/S ratio | 2.66 | N/A |
| P/B ratio | 2.05 | N/A |
Profitability
| Metric | CNSY | MDCX |
|---|---|---|
| Gross margin | 89.58% | 0.00% |
| Operating margin | -293.46% | 0.00% |
| Net margin | -620.70% | 0.00% |
| ROE | -477.54% | N/A |
| ROIC | -479.39% | -269.16% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.